Medical Journals Mull Hedge Fund Disclosures

Jan 20 2011 | 2:59am ET

More than a dozen top medical research journals are to consider requiring authors to disclose payments from hedge funds and other investment firms.

The move by the New England Journal of Medicine, Journal of the American Medical Association, The Lancet and 11 other publications follows the arrest of a doctor for allegedly passing confidential information about a drug trial to hedge fund FrontPoint Partners. Yves Benhamou was an adviser to the drug market, Human Genome Sciences, as well as to several hedge funds.

The 14 members of the International Committee of Medical Journal Editors will discuss a possible disclosure requirement at their annual meeting in June. Researchers are already required to disclose financial relationships with drug and medical device makers.

Medical journals are scoured by health-care investors, and articles can have a major impact on the market.


In Depth

Exotic Assets: Investing In Rare Violins

Jan 17 2017 | 4:43pm ET

By definition, alternative investments include exotic assets far beyond your typical...

Lifestyle

'Tis the Season: Wall Street Holiday Parties Back In Fashion

Dec 22 2016 | 9:23pm ET

Spending on Wall Street holiday parties has largely returned to pre-2008 levels...

Guest Contributor

The Trump Administration: What It Could Mean for Carried Interest

Jan 19 2017 | 5:25pm ET

The arrival of the Trump administration brings the potential for a repeal of the...

 

From the current issue of

Versum Materials (VSM), with a market capitalization of $2.7 billion, enables chipmakers to achieve higher performance at lower cost with enhanced reliability. Versum is a leading global provider of electronic materials for the integrated circuit and flat-panel display markets.